RG-6333

• Target:

  Immunology/Inflammation related

• Related Pathways:

  Immunology/Inflammation

• Bioactivity:

  RG-6333 is a bispecific agonist targeting CD19 and CD28. It specifically identifies and binds to the CD19 antigen present on the surface of malignant B cells, effectively targeting tumor cells. By engaging with CD28, RG-6333 activates T cells, overcoming activation barriers and boosting antitumor immunity. RG-6333 is applicable for research in relapsed/refractory non-Hodgkin lymphoma.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C